C07C 47/57
Polycyclic
Official title: polycyclic
C07C47/57 (Polycyclic) appears on 72 US grants and 40 published applications in this corpus.
Search patents in C07C- Granted patents
- 72
- Published applications
- 40
- Assignees
- 54
- Inventors
- 206
- Latest grant
- 18 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 1 | 5 |
| 2005 | 1 | 0 |
| 2006 | 2 | 1 |
| 2007 | 1 | 2 |
| 2008 | 2 | 3 |
| 2009 | 4 | 5 |
| 2010 | 4 | 7 |
| 2011 | 2 | 3 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 2 |
| 2015 | 1 | 0 |
| 2016 | 1 | 3 |
| 2017 | 2 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 2 |
| 2022 | 2 | 2 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Synthetic antibacterial compounds and uses thereof18 Jun 2024US 12,011,422 B2McMaster University
- Liphagal analog and multi-targeted kinase inhibitor containing liphagal or analog thereof4 Jul 2023US 11,691,980 B2Tohoku University
- Polysubstituted benzene, preparation method thereof, and method of using the same5 Jul 2022US 11,376,228 B2Genifarm Laboratories Inc
- Compounds as modulators of TLR2 signaling31 May 2022US 11,345,713 B2Neuropore Therapies, Inc.
- Compounds from invasive Salvinias and methods of using the same5 Nov 2019US 10,464,963 B2Stephen F. Austin State University
- Synthetic Antibacterial Compounds and Uses Thereof22 Dec 2022US 2022/0401384 A1McMaster University
- Compounds as modulators of tlr2 signaling15 Dec 2022US 2022/0396583 A1Neuropore Therapies, Inc.
- Liphagal analog and multi-targeted kinase inhibitor containing liphagal or analog thereof1 Jul 2021US 2021/0198271 A1Tohoku University
- Compounds as modulators of tlr2 signaling28 Jan 2021US 2021/0024539 A1Neuropore Therapies, Inc.
- Asymmetric derivatives of polyphenols of the dinaphthaline series, process of preparing and use thereof26 Nov 2020US 2020/0369618 A1Nearmedic International Limited
Most cited
By later US patents
- Bicyclic naphthalenic derivatives, a process for preparing the same and human or veterinary medicines and cosmetic compositions containing said derivatives142US 4,826,969 ACentre International de Recherches Dermatologiques (C.I.R.D.) · 1989
- Diarylacetylenes and their use in treating acne83US 4,806,558 ABASF SE · 1989
- Substituted biphenyl compounds36US 5,877,190 AAdir et Compagnie · 1999
- Derivatives of naphthalene with COMT inhibiting activity29US 6,903,114 B2Orion Corporation · 2005
- Process for preparing 2-hydroxybenzoic aldehydes22US 4,151,201 AMontedison S.p.A. · 1979